Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4- S-Cysteaminylphenol and 4-S-Cysteaminylcatechol

Biochemical Pharmacology

Volumn 53, Issue 10, 1997, Pages 1435-1444

  Hasegawa, Katsutoshi ^a   Ito, Shosuke ^b   Inoue, Shigeki ^b   Wakamatsu, Kazumasa ^b   Ozeki, Hiroyuki ^a   Ishiguro, Isao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Catechol; Cytotoxicity; Melanocyte; Melanoma; Phenol; Tyrosinase

Indexed keywords

4 S CYSTEAMINYLPHENOL; ALCOHOL DEHYDROGENASE; CATECHOL; GLUTATHIONE; PHENOL DERIVATIVE; TYROSINE DERIVATIVE;

ANIMAL CELL; ARTICLE; AUTOOXIDATION; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CATALASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEAMINE; DRUG SCREENING ASSAYS, ANTITUMOR; MELANOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; MONOPHENOL MONOOXYGENASE; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE; THIAZINES; TUMOR CELLS, CULTURED;

EID: 0030737929     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00075-0     Document Type: Article

References (29)

1. Prota G, Melanins and Melanogenesis. Academic Press, New York, 1992.
2. Prota G, d'Ischia M and Mascagna D, Melanogenesis as a targeting strategy against metastatic melanoma: A reassessment. Melanoma Res 4: 351-358, 1994.
3. Riley PA, Hydroxyanisole depigmentation: In vitro studies. J Pathol 97: 193-206, 1969.
4. Riley PA, Hydroxyanisole: Recent Advances in Antimelanoma Therapy. IRL Press, Oxford, 1984.
5. Mascagna D, Costantini C, d'Ischia M and Prota G, Biomimetic oxidation of the antimelanoma agent 4-S-cysteaminylphenol and related catechol thioethers: Isolation and reaction behaviour of novel dihydrobenzothiazinequinones. Tetrahedron 50: 8757-8764, 1994.
6. Ito S, Kato T, Ishikawa K, Kasuga T and Jimbow K, Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Biochem Pharmacol 36: 2007-2011, 1987.
7. Yamada I, Seki S, Ito S, Suzuki S, Matsubara O and Kasuga T, The killing effect of 4-S-cysteaminylphenol, a newly synthesized melanin precursor, on B16 melanoma cell lines. Br J Cancer 63: 187-190, 1991.
8. Kitagawa M, Nemoto T, Seki S, Ito S and Kasuga T, In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma. J Cancer Res Clin Oncol 119: 470-474, 1993.
9. Miura S, Jimbow K and Ito S, The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its N-acetyl derivative. Int J Cancer 46: 931-934, 1990.
10. Alena F, Jimbow K and Ito S, Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. Cancer Res 50: 3743-3747, 1990.
11. Herman HH, Pollock SH, Fowler LC and May SW, Demonstration of the potent antihypertensive activity of phenyl-2-aminoethyl sulfides. J Cardiovasc Pharmacol 11: 501-510, 1988.
12. Inoue S, Ito S, Wakamatsu K, Jimbow K and Fujita K, Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues. Biochem Pharmacol 39: 1077-1083, 1990.
13. Inoue S, Hasegawa K, Ito S, Ozeki H, Solano F, Jiménez-Cervantes C, Wakamatsu K and Fujita K, Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol. Cancer Res 55: 2603-2607, 1995.
14. Padgette SR, Herman HH, Han JH, Pollock SH and May SW, Antihypertensive activities of phenyl aminoethyl sulfides: A class of synthetic substrates for dopamine β-hydroxylase. J Med Chem 27: 1354-1357, 1984.
15. Imai Y, Ito S and Fujita K, Determination of natural thiols by liquid chromatography after derivatization with 3,5-di-tertbutyl-1,2-benzoquinone. J Chromatogr 420: 404-410, 1987.
16. Roth M, Fluorimetric assay of enzymes. In: Methods in Biochemical Analysis (Ed. Glick D), pp. 189-285. Interscience Publishers, New York, 1969.
17. Cooksey CJ, Jimbow K, Land EJ and Riley PA, Reactivity of orthoquinones involved in tyrosinase-dependent cytotoxicity: Differences between alkylthio- and alkoxy-substituents. Melanoma Res 2: 283-293, 1992.
18. +]-ATPase of Neurospora crassa by N-ethylmaleimide. Protection by nucleotides. J Biol Chem 257: 12051-12055, 1982.
19. Morrison ME, Yagi M and Cohen G, In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Proc Natl Acad Sci USA 82: 2960-2964, 1985.
20. Cooksey CJ, Land EJ, Ramsden CA and Riley PA, Tyrosinase-mediated cytotoxicity of 4-substituted phenols: Quantitative structure-thiol-reactivity relationships of the derived o-quinones. Anticancer Drug Des 10: 119-129, 1995.
21. Prezioso JA, Wang N and Bloomer WD, Thymidylate synthase as a target enzyme for the melanoma-specific toxocity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol. Cancer Chemother Pharmacol 30: 394-400, 1992.
22. Alena F, Iwashina T, Gili A and Jimbow K, Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res 54: 2661-2666, 1994.
23. Griffith OW and Meister A, Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254: 7558-7560, 1979.
24. Alena F, Dixon W, Thomas P and Jimbow K, Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S-cysteaminylphenol in black and yellow hair follicles. J Invest Dermatol 104: 792-797, 1995.
25. Peinado P, Martinez-Liarte JH, del Marmol V, Solano F and Lozano JA, Glutathione depletion in mouse melanoma cells increases their sensitivity to oxidative lysis. Cancer J 5: 348-353, 1992.
26. Picardo M, Passi S, Nazzaro-Porro M, Breathnach A, Zompetta C, Faggioni A and Riley P, Mechanism of antitumoral activity of catechols in culture. Biochem Pharmacol 36: 417-425, 1987.
27. Graham DG, Tiffany SM, Bell WR Jr and Gutknecht WF, Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653, 1978.
28. Tiffany-Castiglioni E, Saneto RP, Proctor PH and Perez-Polo JR, Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. Biochem Pharmacol 31: 181-188, 1981.
29. Heikkila RE and Cohen G, 6-Hydroxydopamine: Evidence for superoxide radical as an oxidative intermediate. Science 181: 456-457, 1973.